0:  a Effects of CCl 4, MpEO and their combinations MpEO/CCl 4 on hepatic TBARS of control (Con) and experimental rats.
1: Con, control group; mod, CCl 4-model group ; SL/CCl 4, silymarin 50 mg/kg + CCl 4; MpEO/CCl 4 5 mg/kg + CCl 4 group; MpEO/CCl 4 15 mg/kg + CCl 4 group; MpEO/CCl 4 40 mg/kg + CCl 4 group; MpEO 40 mg/kg group.
2: Values are mean  SEM for ten rats in each group.
3: CCl 4, MpEO, MpEO/CCl 4 treated groups vs control group; * p < 0.05, ** p < 0.01, *** p < 0.001, CCl 4 group vs (MpEO/CCl 4) group; # p < 0.05, ## p < 0.01, ### p < 0.001. b.
4: Effects of CCl 4, MpEO and their combinations (MpEO/CCl 4 ) on kidney TBARS of control (Con) and experimental rats.
5: Con, control group; mod, CCl4-model group ; SL/CCl 4, silymarin 50 mg/kg + CCl 4; MpEO/CCl 4 5 mg/kg + CCl 4 group; MpEO/CCl 4 15 mg/kg + CCl4 group; MpEO/CCl 4 40 mg/kg + CCl4 group; MpEO 40 mg/kg.
6: Values are mean  SEM for ten rats in each group.
7: CCl 4, MpEO, MpEO/CCl 4 treated groups vs control group; * p < 0.05, ** p < 0.01, *** p < 0.001, CCl 4 group vs (MpEO/CCl 4) group; # p < 0.05, ## p < 0.01, ### p < 0.001 )  )  Fig.
8: 1)
